Although data based on cellular and animal models have explored some mechanisms on IGF-I-induced EMT and tumor metastasis, complexity of cancer biology and heterogeneous of tumor bring a slew of setbacks for the IGF-IR-targeted therapies. The gene discussed is IGF1; the disease is neoplasm.